Galectin Therapeutics CMO Jamil Khurram disposes of 16,250 common shares for $83,284.5 - GALT News | RalliesGalectin Therapeutics CMO Jamil Khurram disposes of 16,250 common shares for $83,284.5
G
GALT• Chief medical officer exercises and sells shares
- Galectin Therapeutics Chief Medical Officer Jamil Khurram exercised options for 16,250 common shares at $3.04 on July 14.
- He sold 16,250 common shares the same day at a weighted average price of $5.13, ending with zero shares directly owned.
- He reported 48,750 stock options held following the transaction.
YUM
•
